BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36528257)

  • 1. Informational Preferences of Women Seeking Treatment for Symptomatic Uterine Fibroids: A Qualitative Study.
    Wolgemuth T; Suresh N; Holder K; Milad MP
    J Minim Invasive Gynecol; 2023 Apr; 30(4):284-289. PubMed ID: 36528257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
    Zurawin RK; Fischer JH; Amir L
    J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique Learning System for Uterine Artery Embolization for Symptomatic Myoma and Adenomyosis for Obstetrician-Gynecologists in Cooperation with Interventional Radiologists: Evaluation of UAE From the Point of View of Gynecologists Who Perform UAE.
    Soeda S; Hiraiwa T; Takata M; Kamo N; Sekino H; Nomura S; Kojima M; Kyozuka H; Ozeki T; Ishii S; Tameda T; Asano K; Miyazaki M; Takahashi T; Watanabe T; Taki Y; Fujimori K
    J Minim Invasive Gynecol; 2018 Jan; 25(1):84-92. PubMed ID: 28807810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specialty-Specific Values Affecting the Management of Symptomatic Uterine Fibroids.
    Keller EJ; Crowley-Matoka M; Collins JD; Chrisman HB; Milad MP; Vogelzang RL
    J Vasc Interv Radiol; 2017 Mar; 28(3):420-428. PubMed ID: 28082073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
    Daniels J; Middleton LJ; Cheed V; McKinnon W; Rana D; Sirkeci F; Manyonda I; Belli AM; Lumsden MA; Moss J; Wu O; McPherson K
    Health Technol Assess; 2022 Apr; 26(22):1-74. PubMed ID: 35435818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial.
    de Bruijn AM; Ankum WM; Reekers JA; Birnie E; van der Kooij SM; Volkers NA; Hehenkamp WJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):745.e1-745.e12. PubMed ID: 27393268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
    Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
    Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Altered Perception of Normal: Understanding Causes for Treatment Delay in Women with Symptomatic Uterine Fibroids.
    Ghant MS; Sengoba KS; Vogelzang R; Lawson AK; Marsh EE
    J Womens Health (Larchmt); 2016 Aug; 25(8):846-52. PubMed ID: 27195902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine artery embolization for symptomatic uterine fibroids.
    Gupta JK; Sinha A; Lumsden MA; Hickey M
    Cochrane Database Syst Rev; 2014 Dec; (12):CD005073. PubMed ID: 25541260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
    Babashov V; Palimaka S; Blackhouse G; O'Reilly D
    Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "I Wasn't Presented With Options": Perspectives of Black Veterans Receiving Care for Uterine Fibroids in the Veterans Health Administration.
    Carey C; Silvestrini M; Callegari LS; Katon JG; Bossick AS; Doll KM; Christy A; Washington DL; Owens S
    Womens Health Issues; 2023; 33(6):652-660. PubMed ID: 37689493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH; Sahota DS; Yuen PM
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
    McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
    Trials; 2014 Nov; 15():468. PubMed ID: 25432688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic management of uterine fibroid tumors: updated French guidelines.
    Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized prospective trial of the postoperative quality of life between laparoscopic uterine artery ligation and laparoscopy-assisted vaginal hysterectomy for the treatment of symptomatic uterine fibroids: clinical trial design.
    Kim HS; Kim JW; Kim MK; Chung HH; Lee TS; Jeon YT; Kim YB; Jeon HW; Yun YH; Park NH; Song YS; Kang SB
    Trials; 2009 Jan; 10():8. PubMed ID: 19178748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine artery embolization as a treatment option for uterine myomas.
    Marshburn PB; Matthews ML; Hurst BS
    Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
    Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
    Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.